Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2018 Sep 23:2018:bcr2018226165.
doi: 10.1136/bcr-2018-226165.

Novel mutation in the CHST14 gene causing musculocontractural type of Ehlers-Danlos syndrome

Affiliations
Case Reports

Novel mutation in the CHST14 gene causing musculocontractural type of Ehlers-Danlos syndrome

Sapna Sandal et al. BMJ Case Rep. .

Abstract

Musculocontractural type of Ehlers-Danlos syndrome (MC-EDS) is a recently recognised connective tissue disorder. MC-EDS is caused by homozygous or compound heterozygous mutation in the carbohydrate sulfotransferase 14 (CHST14) gene on chromosome 15q15. Herein, we report a case of a 3-year-old boy with MC-EDS in whom a novel mutation in the CHST14 gene was discovered. Besides being the second report of this rare disorder from India, the child till 3 years has not had any bleeding tendency as described in the earlier reports of this disorder.

Keywords: developmental paediatrocs; genetics; musculoskeletal and joint disorders.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
(A) Characteristic facial features of the index case with MC-EDS. Note synophrys, hypertelorism, down slanting palpebral fissures, low set ears, thin upper lip and prominent nasolabial folds. (B) Hands of child showing tapering fingers with bilaterally thin and adducted thumbs. (C) Feet showing bilateral talipes equinovarus deformity. MC-EDS, musculocontractural type of Ehlers-Danlos syndrome.
Figure 2
Figure 2
Photographs of the affected child taken at (A) 3 months, (B) 1 year, (C) 2 years.
Figure 3
Figure 3
Bidirectional Sanger sequence of (A) proband showing homozygous non-sense mutation NM_130468.3:c.797dupA (p.Tyr266*) (B) parents showing the heterozygous carrier status.

Similar articles

Cited by

References

    1. Steinmann B, Royce PM, Superti-Furga A. The Ehlers-Danlos syndrome : Royce PM, Steinmann B, Connective tissue and its heritable disorders. Hoboken, NJ, USA: John Wiley & Sons, Inc, 2002:431–523.
    1. Beighton P, De Paepe A, Steinmann B, et al. . Ehlers-Danlos syndromes: revised nosology, Villefranche, 1997. Ehlers-Danlos National Foundation (USA) and Ehlers-Danlos Support Group (UK). Am J Med Genet 1998;77:31–7. - PubMed
    1. De Paepe A, Malfait F. The Ehlers-Danlos syndrome, a disorder with many faces. Clin Genet 2012;82:1–11. 10.1111/j.1399-0004.2012.01858.x - DOI - PubMed
    1. Castori M, Morlino S, Celletti C, et al. . Re-writing the natural history of pain and related symptoms in the joint hypermobility syndrome/Ehlers-Danlos syndrome, hypermobility type. Am J Med Genet A 2013;161A:2989–3004. 10.1002/ajmg.a.36315 - DOI - PubMed
    1. Malfait F, Francomano C, Byers P, et al. . The 2017 international classification of the Ehlers-Danlos syndromes. Am J Med Genet C Semin Med Genet 2017;175:8–26. 10.1002/ajmg.c.31552 - DOI - PubMed

Publication types

Supplementary concepts

LinkOut - more resources